Zhi-Ming Ding
6Patents
1h-index
13Co-inventors
48Inventor score
Filing activity: Feb 27, 1995 → Mar 20, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5766899A | Targeted nucleic acid delivery into liver cells | Emerging Cross-Sectional Technologies | 13 | Expired |
| US11549112B1 | RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use | Chemistry; Metallurgy | 1 | Active |
| US11629349B2 | RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use | Chemistry; Metallurgy | 1 | Active |
| US12054718B2 | RNAi agents for inhibiting expression of PNPLA3, pharmaceutical compositions thereof, and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11845937B2 | RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12378558B2 | RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutical compositions thereof, and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.